MedPath

Abbreviated MRI for HCC Surveillance

Not Applicable
Active, not recruiting
Conditions
Chronic Hepatitis
Hepatocellular Carcinoma
Liver Cirrhosis
Interventions
Diagnostic Test: Biannual ultrasonography
Diagnostic Test: Annual abbreviated liver MRI
Registration Number
NCT03731923
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study aims to investigate the clinical feasibility of abbreviated liver MRI for HCC surveillance in a high-risk group.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
257
Inclusion Criteria
  • high risk of HCC development (chronic hepatitis B, chronic hepatitis C, liver cirrhosis)
  • no history of HCC
  • on surveillance of HCC using ultrasonography
  • sign informed consent
Exclusion Criteria
  • history of HCC
  • congestive hepatopathy
  • iron deposition
  • any absolute or relative contra-indication of contrast-enhanced MRI

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
High risk group of HCCBiannual ultrasonographyHigh risk group of HCC with chronic hepatitis or liver cirrhosis. Participants undergo biannual ultrasonography and annual abbreviated liver MRI.
High risk group of HCCAnnual abbreviated liver MRIHigh risk group of HCC with chronic hepatitis or liver cirrhosis. Participants undergo biannual ultrasonography and annual abbreviated liver MRI.
Primary Outcome Measures
NameTimeMethod
Sensitivity for detecting HCC12 months after last MRI

Sensitivity for detecting HCC

Secondary Outcome Measures
NameTimeMethod
Specificity for detecting HCC12 months after last MRI

Specificity for detecting HCC

Table time of abbreviated MRI1 day after each MRI

time from scan start and scan end

Image quality of abbreviated liver MRI12 months after last MRI

qualitative analysis on four-point scale

In-room time of abbreviated MRI1 day after each MRI

interval between participants' walk-in and walk-out times

Sensitivity for detecting early stage HCC12 months after last MRI

Sensitivity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)

Specificity for detecting early stage HCC12 months after last MRI

Specificity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)

Trial Locations

Locations (2)

The Catholic University of Korea, Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath